ACURATE neo2 TAVI achieves high success in severe bicuspid aortic stenosis, demonstrating strong 30-day safety and efficacy.

Women are often underdiagnosed and undertreated when it comes to heart disease, particularly conditions like aortic stenosis.

GlobalData’s latest report reveals that India accounted for only around 3 per cent of the market in APAC in 2024, due to ...

AISAP, a medical technology company developing AI-powered Point-of-Care Assisted Diagnosis (POCAD™) solutions to transform ...

NewsVoir New Delhi [India] 3 Indraprastha Apollo Hospitals proudly announces the launch of its Heart Valve Clinic a dedicated ...

1 Department of Cardiology, Hospital Virgen de la Salud, Toledo, Spain 2 Laboratory of Vascular Pathophysiology, Hospital Nacional de Parapléjicos, SESCAM, Toledo, Spain Aortic stenosis (AS ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality. Despite advancements in emergency interventions, the optimal treatment ...

The aortic valve, influenced by factors such as endothelial dysfunction, inflammation, oxidative stress, lipid metabolism disorders, calcium deposition, and extracellular matrix remodeling, undergoes ...

Department of Cardiology, Odense University Hospital, Denmark (N.S.B.M., J.S.D., M.A., A.H., R.C.-S., J.E.M., K.A.Ø., M.-A.C.). Research center, Institut ...